How likely do patients develop again cancer after a tumor has been surgically removed? This is the central question of the new research project „MelEVIR – Melanoma, Extracellular Vesicles, and Immune Response“.
Prof. Dr. Lisa Gabel, neuroscientist at Lafayette College in Pennsylvania (USA) and Alexander von Humboldt Research Fellow, will carry out a clinical study about dyslexia in children with German as a mother tongue at the Division of Child and Adolescent Mental Health
On March 3rd, a small group of FAU /UK employees, postdocs and doctoral students from Germany, Brazil, Poland, Yemen, Iraq and Italy met for the time in the frame of the FAU Newcomers' Club
FAU’s Newcomers’ Club, initiated by the Faculty of Medicine and starting on March 3rd, is a platform for newcomers from all countries and their families.
Fast metastasis and resistance to treatment are characteristic of aggressive types of cancer. They are also the main causes of cancer-related death. Researchers at FAU have recently made a discovery that could change this. They have discovered a mechanism that promotes metastasis and causes tumors to become resistant to treatment.
Clinician scientists around Dr. N. Savaskan developed a new cell culture technique that allows the processes of tumor growth to be studied directly and in real time. This new method will allow new medications and therapies to be analyzed directly, and enable side effects to be identified more quickly and efficiently than when using conventional cell culture techniques.
The German Research Foundation (DFG) supports a new research training group (GRK) for the coming 4.5 years with a focus on interdisciplinarity and neurosciences: "Neurodevelopment and CNS Vulnerability" (Speaker: Prof. Dr. D.C. Lie, Institute of Biochemistry).
